Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Not applicableLooking for participantsNCT06515106
What this trial is testing

Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease

Who this might be right for
Limbic Encephalitis With LGI1 Antibodies
Fundacion Clinic per a la Recerca Biomédica 20
Large-scale testing (Phase 3)Study completedNCT02636699
What this trial is testing

Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy

Who this might be right for
Peanut Allergy
DBV Technologies 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04725474
What this trial is testing

First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)

Who this might be right for
Solid Tumor, Adult
CatalYm GmbH 199
Not applicableUnknownNCT04295785
What this trial is testing

Juvenile Autoimmune Necrotizing Myopathies

Who this might be right for
Immune-Mediated Necrotizing Myopathy
Central Hospital, Nancy, France 10
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Early research (Phase 1)Study completedNCT01489358
What this trial is testing

Chikungunya Virus Vaccine Trial in Healthy Adults

Who this might be right for
Viral VaccinesChikungunya FeverChikungunya Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableUnknownNCT05913596
What this trial is testing

The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation

Who this might be right for
Antibody-mediated RejectionKidney Tranplant
First Affiliated Hospital of Zhejiang University 15
Not applicableUnknownNCT06183788
What this trial is testing

Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage

Who this might be right for
Anti-NMDA Receptor Encephalitis
Fundacion Clinic per a la Recerca Biomédica 20
Not applicableLooking for participantsNCT05004493
What this trial is testing

Biorepository and Registry for Plasma Exchange Patients

Who this might be right for
Antibody-mediated RejectionNMO Spectrum DisorderTTP+1 more
Charles M Knudson 200
Not applicableNot Yet RecruitingNCT07005687
What this trial is testing

Using MSCs for Chronic Active Antibody Mediated Rejection

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 10
Not applicableStudy completedNCT02533596
What this trial is testing

Elimination of Cardiac and Inflammatory Biomarkers and Adipokines by Therapeutic Plasma Exchange

Who this might be right for
Antibody-mediated RejectionAutoimmune Reaction Mediated by Immune Complex
Hannover Medical School 21
Testing effectiveness (Phase 2)WithdrawnNCT02113891
What this trial is testing

Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07764627
What this trial is testing

Study of SG301 for Renal AMR After Transplantation

Who this might be right for
Antibody Mediated Rejection
Hangzhou Sumgen Biotech Co., Ltd. 10
Large-scale testing (Phase 3)Enrolling By InvitationNCT06801886
What this trial is testing

Silymarin's Advantage on Graft Effectiveness

Who this might be right for
Posttransplant Diabetes MellitusAcute Graft RejectionBiopsy Proven Acute Rejection+2 more
University Hospital, Martin 130
Not applicableLooking for participantsNCT06774365
What this trial is testing

CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation

Who this might be right for
Heart TransplantationRejection Heart TransplantHLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna 683